Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · IEX Real-Time Price · USD

7.54

-0.60 (-7.37%)

At close: Jul 2, 2024, 4:00 PM

7.56

+0.02 (0.27%)

After-hours: Jul 2, 2024, 7:57 PM EDT

Summit Therapeutics Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-614.93	-78.78	-88.6	-52.7	-	Upgrade
Depreciation & Amortization	2.05	2.51	2.46	2	2.13	Upgrade
Share-Based Compensation	14.11	11.95	12.8	1.77	1.1	Upgrade
Other Operating Activities	522.01	22.74	0.76	0.82	-29.21	Upgrade
Operating Cash Flow	-76.76	-41.58	-72.59	-48.11	-25.98	Upgrade
Capital Expenditures	0.1	-0.62	-0.31	-0.42	-0.27	Upgrade
Acquisitions	-475.02	0	0	0	-0.91	Upgrade
Change in Investments	-112.86	0	0	0	-	Upgrade
Other Investing Activities	-	-	-	-	0.74	Upgrade
Investing Cash Flow	-587.77	-0.62	-0.31	-0.42	-0.44	Upgrade
Share Issuance / Repurchase	111.2	100.29	77.97	50.55	62.5	Upgrade
Debt Issued / Paid	-24.69	519.96	-0.05	0	-0.59	Upgrade
Other Financing Activities	-	-	-	-	-1.16	Upgrade
Financing Cash Flow	86.51	620.24	77.92	50.55	60.75	Upgrade
Exchange Rate Effect	0.84	-1.22	0.35	0.56	1.43	Upgrade
Net Cash Flow	-577.18	576.82	5.37	2.58	34.33	Upgrade
Free Cash Flow	-76.66	-42.21	-72.89	-48.53	-26.25	Upgrade
Free Cash Flow Margin	-	-5986.67%	-4029.46%	-5643.26%	-	Upgrade
Free Cash Flow Per Share	-0.12	-0.22	-0.55	-0.70	-0.82	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).